PMC:7161517 / 15471-15757 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T87","span":{"begin":125,"end":131},"obj":"Body_part"},{"id":"T88","span":{"begin":231,"end":235},"obj":"Body_part"},{"id":"T89","span":{"begin":255,"end":259},"obj":"Body_part"}],"attributes":[{"id":"A87","pred":"fma_id","subj":"T87","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A88","pred":"fma_id","subj":"T88","obj":"http://purl.org/sig/ont/fma/fma67122"},{"id":"A89","pred":"fma_id","subj":"T89","obj":"http://purl.org/sig/ont/fma/fma67122"}],"text":"ricular remodeling and dysfunction exhibited partial resolution following losartan and olmesartan treatment while augmenting plasma concentrations of the angiotensins (46). This was associated with recovery of cardiac AT1 receptor mRNA and increased ACE2 mRNA post-myocardial infarction"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T64","span":{"begin":218,"end":221},"obj":"Disease"},{"id":"T65","span":{"begin":265,"end":286},"obj":"Disease"}],"attributes":[{"id":"A64","pred":"mondo_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"},{"id":"A65","pred":"mondo_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"}],"text":"ricular remodeling and dysfunction exhibited partial resolution following losartan and olmesartan treatment while augmenting plasma concentrations of the angiotensins (46). This was associated with recovery of cardiac AT1 receptor mRNA and increased ACE2 mRNA post-myocardial infarction"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T157","span":{"begin":125,"end":131},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"ricular remodeling and dysfunction exhibited partial resolution following losartan and olmesartan treatment while augmenting plasma concentrations of the angiotensins (46). This was associated with recovery of cardiac AT1 receptor mRNA and increased ACE2 mRNA post-myocardial infarction"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T210","span":{"begin":74,"end":82},"obj":"Chemical"},{"id":"T211","span":{"begin":87,"end":97},"obj":"Chemical"}],"attributes":[{"id":"A210","pred":"chebi_id","subj":"T210","obj":"http://purl.obolibrary.org/obo/CHEBI_6541"},{"id":"A211","pred":"chebi_id","subj":"T211","obj":"http://purl.obolibrary.org/obo/CHEBI_48416"}],"text":"ricular remodeling and dysfunction exhibited partial resolution following losartan and olmesartan treatment while augmenting plasma concentrations of the angiotensins (46). This was associated with recovery of cardiac AT1 receptor mRNA and increased ACE2 mRNA post-myocardial infarction"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T17","span":{"begin":265,"end":286},"obj":"Phenotype"}],"attributes":[{"id":"A17","pred":"hp_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/HP_0001658"}],"text":"ricular remodeling and dysfunction exhibited partial resolution following losartan and olmesartan treatment while augmenting plasma concentrations of the angiotensins (46). This was associated with recovery of cardiac AT1 receptor mRNA and increased ACE2 mRNA post-myocardial infarction"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T590","span":{"begin":74,"end":82},"obj":"CHEBI:4670;CHEBI:4670"},{"id":"T591","span":{"begin":125,"end":131},"obj":"UBERON:0001969"},{"id":"T592","span":{"begin":210,"end":217},"obj":"UBERON:0000948"},{"id":"T593","span":{"begin":218,"end":221},"obj":"PR:000001251"},{"id":"T594","span":{"begin":250,"end":254},"obj":"PR:000003622;G_3;PG_10"},{"id":"T595","span":{"begin":265,"end":275},"obj":"UBERON:0002349"},{"id":"T59750","span":{"begin":7,"end":11},"obj":"NCBITaxon:10114"},{"id":"T68812","span":{"begin":17,"end":21},"obj":"UBERON:0001652"},{"id":"T80708","span":{"begin":22,"end":37},"obj":"UBERON:0001626"},{"id":"T19064","span":{"begin":51,"end":61},"obj":"UBERON:0002349"},{"id":"T68086","span":{"begin":74,"end":80},"obj":"UBERON:0001969"},{"id":"T9555","span":{"begin":81,"end":87},"obj":"PR:000036009"},{"id":"T46842","span":{"begin":122,"end":128},"obj":"UBERON:0001969"},{"id":"T63923","span":{"begin":129,"end":133},"obj":"PR:000003622;G_3;PG_10"},{"id":"T57073","span":{"begin":168,"end":175},"obj":"UBERON:0000948"},{"id":"T11029","span":{"begin":176,"end":180},"obj":"PR:000003622;G_3;PG_10"},{"id":"T22615","span":{"begin":185,"end":188},"obj":"PR:000001251"}],"text":"ricular remodeling and dysfunction exhibited partial resolution following losartan and olmesartan treatment while augmenting plasma concentrations of the angiotensins (46). This was associated with recovery of cardiac AT1 receptor mRNA and increased ACE2 mRNA post-myocardial infarction"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"701","span":{"begin":250,"end":254},"obj":"Gene"},{"id":"740","span":{"begin":74,"end":82},"obj":"Chemical"},{"id":"741","span":{"begin":87,"end":97},"obj":"Chemical"},{"id":"748","span":{"begin":265,"end":286},"obj":"Disease"}],"attributes":[{"id":"A701","pred":"tao:has_database_id","subj":"701","obj":"Gene:302668"},{"id":"A740","pred":"tao:has_database_id","subj":"740","obj":"MESH:D019808"},{"id":"A741","pred":"tao:has_database_id","subj":"741","obj":"MESH:C437965"},{"id":"A748","pred":"tao:has_database_id","subj":"748","obj":"MESH:D009203"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ricular remodeling and dysfunction exhibited partial resolution following losartan and olmesartan treatment while augmenting plasma concentrations of the angiotensins (46). This was associated with recovery of cardiac AT1 receptor mRNA and increased ACE2 mRNA post-myocardial infarction"}

    2_test

    {"project":"2_test","denotations":[{"id":"32305401-15007027-55252957","span":{"begin":168,"end":170},"obj":"15007027"}],"text":"ricular remodeling and dysfunction exhibited partial resolution following losartan and olmesartan treatment while augmenting plasma concentrations of the angiotensins (46). This was associated with recovery of cardiac AT1 receptor mRNA and increased ACE2 mRNA post-myocardial infarction"}